The Cancer Research Institute (CRI), established in 1953, is the world’s only nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts that are leading to new and effective immune system-based strategies to treat, control, and prevent cancer. Guided by a world-renowned Scientific Advisory Council that includes 3 Nobel laureates and 26 members of the National Academy of Sciences, CRI supports research conducted by immunologists and tumor immunologists at leading medical centers and universities across the globe, and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment.
The Cancer Research Institute has one of the lowest overhead expense ratios among nonprofit organizations, with 88 percent of its resources going directly to the support of its science, medical, and research programs. Charity Navigator, the nation's largest and most utilized evaluator of charities, rates CRI 4 out of 4 stars. CRI meets or exceeds all 20 standards of the Better Business Bureau Wise Giving Alliance, the most comprehensive U.S. charity evaluation service, and has earned the GuideStar Exchange Gold Seal, indicating our commitment to the transparency of our organizational information to donors, funders, those we serve, the public, and regulators. CRI has also received an ‘A’ grade for fiscal disclosure and efficiency from CharityWatch, as well as top accolades from other charity watchdog organizations. For more information, visit http://www.cancerresearch.org .